These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3596345)

  • 1. [Distribution of ciprofloxacin in serum and gynecologic tissues].
    Gerstner GJ; Kronich W; Dalhoff A; Weuta H
    Gynakol Rundsch; 1987; 27(1):1-9. PubMed ID: 3596345
    [No Abstract]   [Full Text] [Related]  

  • 2. Penetration of ciprofloxacin into gynecologic tissues.
    Dalhoff A; Weuta H
    Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
    el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
    Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the bioequivalence of ciprofloxacin 500 mg orally versus 200 mg i.v.
    Garraffo R; Lapalus P; Dellamonica P; Bernard E; Etesse H
    Chemioterapia; 1987 Jun; 6(2 Suppl):298-300. PubMed ID: 3509420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ciprofloxacin levels in pleural fluid and serum during systemic administration after pneumonectomy].
    Padberg WM; Jäger E; Buhr J; Zimmermann T
    Zentralbl Chir; 2000; 125(5):450-3. PubMed ID: 10929630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing.
    Caruso E; Castro JM; Chamoles N; Galimberti R; Jorge L; Rohwedder R
    J Chemother; 1989 Jul; 1(4 Suppl):549-51. PubMed ID: 16312527
    [No Abstract]   [Full Text] [Related]  

  • 7. Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.
    Goormans E; Dalhoff A; Kazzaz B; Branolte J
    Chemotherapy; 1986; 32(1):7-17. PubMed ID: 2936582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S
    Vet Ther; 2001; 2(2):120-8. PubMed ID: 19753704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
    Bidgood TL; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
    Davis JL; Papich MG; Weingarten A
    J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of ciprofloxacin and metronidazole in human tissues during abdominal surgery.
    Hopf G; Boecker R; Benz K; Stuetz G
    J Chemother; 1989 Jul; 1(4 Suppl):562-4. PubMed ID: 16312533
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftriaxone in serum and in gynecological tissues.
    Götz A; Weissenbacher ER; Gutschow K; Wachter I; Schneider A
    Acta Eur Fertil; 1987; 18(2):127-8. PubMed ID: 3630575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of trough concentrations of oral ciprofloxacin.
    Paladino JA; Forrest A; Wilton JH
    Pharmacotherapy; 1993; 13(5):504-7. PubMed ID: 8247920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin intravenous dose variance.
    Lode H; Hoffken G; Borner K; Koeppe P
    Am J Med; 1989 Nov; 87(5A):40S-45S. PubMed ID: 2589382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
    Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin in normal rabbits and changes observed in induced dehydrated state.
    Bashir S; Jamshaid M; Ahmad B; Iqbal J
    Pak J Pharm Sci; 2008 Jul; 21(3):225-9. PubMed ID: 18614416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.
    Sahai J; Healy DP; Stotka J; Polk RE
    Br J Clin Pharmacol; 1993 Mar; 35(3):302-4. PubMed ID: 8471407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.